Dr. Silke van Koningsbruggen

Cystic Fibrosis Center Cologne, University Hospital

Curriculum vitae

  • 1988–1994 Study of Medicine at Ruprecht-Karls-University Heidelberg
  • 1991 University of Rotterdam/Netherlands (Erasmus Stipend of EU)
  • 1993–1994 Practical Year (DAAD Stipend) Internal Medicine, Baylor Collge of Medicine, Houston, USA
    Pediatrics at University of California, San Diego, USA
    Surgery at Ruprecht-Karls-University Heidelberg
  • 1999 Promotion
  • 1995–1996 „Ärztin im Praktikum” Pediatrics at University of Cologne
  • 1996 Approbation
  • 1996 Residency in Pediatrics at University of Cologne Since
  • 1995 Pediatric Pulmonology, Allergology and Cystic Fibrosis
  • 2002 „Fachärztin” Pediatric Medicine, Allergology
  • 2007 Pediatric Pulmonology

Member of

  • German Society for Pediatric Medicine
  • Society for Pediatric Pulmonology (GPP)
  • Society for Pediatric Allergology and Environmental Medicine (GPA)
  • European Cystic Fibrosis Society (ECFS)

Research

  • Bronchial Inflammation

Clinical Studies

  • Bronchiolar Lavage for the Evaluation of Antiinflammatory Treatment
  • Gluthatione in CF
  • Anti-Elastase in CF
  • a1-Antithrypsin in CF
  • Leukotrien-Receptor-Antagonist (LTBIV)-Study in CF
  • Colistin Kinetic Study in CF Patients
  • Colistin Powder Study in CF
  • ELITE (Early Inhaled Tobramycin for Eradication) in CF
  • Tobramycin Inhalation Powder in CF
  • Galileo vibration-a new therapeutic approach to improve muscle function
  • Study of Genotropin in CF
  • CF-associated Diabetes mellitus
02.01.2008